FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Börse Stuttgart 03:54:03 2024-07-15 pm EDT | ||
| 8.14 EUR | -0.85% |
|
| Current month | -7.50% | ||
| 1 month | -3.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-07-15 | 8.14 | -0.85% |
| 24-07-12 | 8.21 | +2.37% |
| 24-07-11 | 8.02 | -4.18% |
| 24-07-10 | 8.37 | -4.34% |
| 24-07-09 | 8.75 | -1.46% |
Delayed Quote Börse Stuttgart
Last update July 15, 2024 at 03:54 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM3R2F |
| ISIN | DE000UM3R2F0 |
| Date issued | 2024-03-28 |
| Strike | 159.7 $ |
| Maturity | Unlimited |
| Parity | 3.57 : 1 |
| Emission price | 9.93 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.93 € |
|---|---|
| Lowest since issue | 7.18 € |
| Spread | 0.1 € |
| Spread % | 1.22% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.1
USD
Average target price
142.7
USD
Spread / Average Target
+11.35%
- Stock Market
- Certificates
- Certificat
